Company news
Haleon Plc (LSE:HLN) news
Haleon Plc news releases on 6ix. Latest, Jul 7, 2025: Historic Proforma Category Financial Performance
Press releases — page 2
Historic Proforma Category Financial Performance
July 7, 2025
Haleon Breaks Ground on new £130m Global Oral Health Innovation Centre
July 4, 2025
Completed acquisition of remaining 12% in China JV
June 27, 2025
HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER
June 24, 2025
Results of Haleon 2025 Annual General Meeting
May 28, 2025
EMTN programme publication of listing particulars
May 7, 2025
Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation
May 1, 2025
2025 Capital Markets Day
May 1, 2025
Board Change
April 30, 2025
Haleon 2025 Q1 Trading Statement
April 30, 2025
Increase ownership of China JV to 100%
April 15, 2025
Notice of Annual General Meeting (AGM)
April 4, 2025
Commencement of Share Buyback Programme
March 28, 2025
Completion of off-market purchase and Total Voting
March 21, 2025
Publication of Annual Report and Form 20-F 2024
March 21, 2025
Haleon
March 19, 2025
Update on off-market purchase alongside Pfizer
March 19, 2025
PRICING OF OFFERING IN HALEON PLC BY PFIZER INC.
March 19, 2025
Proposed off-market purchase alongside Pfizer
March 18, 2025
PROPOSED OFFERING IN HALEON PLC BY PFIZER INC.
March 18, 2025
Haleon Preliminary 2024 Full Year Results
February 27, 2025
Total Voting Rights
February 3, 2025
Completion of additional 33% stake in China JV
December 31, 2024
Board Changes
December 5, 2024
Haleon 2024 Q3 Trading Statement
October 31, 2024
Update on purchase alongside Pfizer offering
October 1, 2024
Pricing of Offering of Ordinary Shares in Haleon
October 1, 2024
Proposed purchase alongside Pfizer offering
September 30, 2024
Proposed Offering of Ordinary Shares in Haleon plc
September 30, 2024
Divestment of NRT business outside US complete
September 30, 2024
Haleon to increase stake in China JV to 88%
September 27, 2024
Haleon plc: EMTN bond offering
September 12, 2024
Director/PDMR Shareholding - amended
September 11, 2024
EMTN Programme: publication of supplement
September 9, 2024
Directorate Change
August 6, 2024
Commencement of On-Market Share Buyback Programme
August 1, 2024
Haleon 2024 Half Year Results
August 1, 2024
Divestment of NRT business outside of the US
June 26, 2024
Disposal of the ChapStick brand completed
May 31, 2024
Results of Haleon 2024 Annual General Meeting
May 8, 2024
EMTN programme: publication of base prospectus
May 7, 2024
Haleon 2024 Q1 Trading Statement
May 1, 2024
Appointment of Dawn Allen as CFO
April 24, 2024
Closing of Secondary Global Offering by Pfizer
March 21, 2024
Final prospectus supplement filed with the SEC
March 20, 2024
Pricing and upsize of Secondary Global Offering
March 19, 2024
Preliminary prospectus supplement filed with SEC
March 18, 2024
Proposed Secondary Global Offering by Pfizer Inc.
March 18, 2024
Publication of Annual Report and Form 20-F 2023
March 15, 2024
Haleon Preliminary 2023 Full Year Results
February 29, 2024